V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023046 | 20009774 | null | 66.7 | Neo-adjuvant (N) | null | 2015-12-16 | FEC + DOCETAXEL | null | N | 20081340 | FEC + DOCETAXEL |
| 20023047 | 20070599 | 1.57 | 77.5 | Not known (9) | 2016-07-12 | 2016-07-28 | FEC + DOCETAXEL | 2 | Y | 20081342 | FEC + DOCETAXEL |
| 20023048 | 20070599 | 1.52 | 52.8 | Adjuvant (A) | 2015-12-02 | 2015-12-16 | FEC + DOCETAXEL | 2 | N | 20081342 | FEC + DOCETAXEL |
| 20023049 | 20009775 | 1.53 | 69 | Neo-adjuvant (N) | 2015-11-29 | 2015-11-29 | FEC 100 + DOCETAXEL | N | N | 20081348 | FEC + DOCETAXEL |
| 20023050 | 20009775 | 1.71 | 58.1 | Curative (C) | 2016-08-20 | 2016-08-20 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20081348 | FEC + DOCETAXEL |
| 20023051 | 20009776 | 0 | 72.3 | Adjuvant (A) | 2015-10-27 | 2015-10-29 | FEC + DOCETAXEL | 02 | N | 20081350 | FEC + DOCETAXEL |
| 20023052 | 20009776 | 1.64 | 51 | Adjuvant (A) | 2018-02-01 | 2018-02-13 | FEC + DOCETAXEL | 2 | N | 20081350 | FEC + DOCETAXEL |
| 20023053 | 20009777 | 1.71 | 76 | Neo-adjuvant (N) | 2017-09-21 | 2017-09-28 | FEC + DOCETAXEL | 99 | N | 20081358 | FEC + DOCETAXEL |
| 20023054 | 20009778 | 1.61 | 50 | Adjuvant (A) | 2015-05-25 | 2015-07-12 | FEC 100 + DOCETAXEL | N | N | 20081363 | FEC + DOCETAXEL |
| 20023055 | 20009779 | 1.66 | 90.5 | Not known (9) | null | 2017-12-17 | FEC + DOCETAXEL | N | N | 20081364 | FEC + DOCETAXEL |
| 20023056 | 20009779 | 1.72 | 86 | Adjuvant (A) | 2017-09-15 | 2017-09-23 | FEC + DOCETAXEL | 02 | N | 20081364 | FEC + DOCETAXEL |
| 20023057 | 20009780 | 1.72 | 66.9 | Neo-adjuvant (N) | 2013-12-19 | 2013-12-19 | FEC + DOCETAXEL | 02 | N | 20081374 | FEC + DOCETAXEL |
| 20023058 | 20009780 | 0 | 78.1 | Not known (9) | 2017-05-30 | 2017-05-30 | FEC + DOCETAXEL | 02 | N | 20081374 | FEC + DOCETAXEL |
| 20023059 | 20009781 | 1.6 | 60.8 | Adjuvant (A) | 2015-02-18 | 2015-03-05 | FEC + DOCETAXEL | 02 | N | 20081381 | FEC + DOCETAXEL |
| 20023060 | 20009782 | 1.62 | 94 | Neo-adjuvant (N) | 2014-01-30 | 2014-02-20 | FEC + DOCETAXEL | 2 | N | 20081392 | FEC + DOCETAXEL |
| 20023061 | 20009783 | null | 81.6 | Adjuvant (A) | 2015-10-11 | 2015-11-03 | FEC 100 + DOCETAXEL | N | N | 20081396 | FEC + DOCETAXEL |
| 20023062 | 20009783 | 1.64 | 77 | Adjuvant (A) | null | 2015-09-06 | FEC + DOCETAXEL | N | N | 20081396 | FEC + DOCETAXEL |
| 20023063 | 20009784 | 1.57 | 60.3 | Neo-adjuvant (N) | null | 2015-11-16 | FEC + DOCETAXEL | N | N | 20081404 | FEC + DOCETAXEL |
| 20023064 | 20009784 | 1.72 | 61.8 | Not known (9) | 2016-05-22 | 2016-05-29 | FEC + DOCETAXEL | 02 | N | 20081404 | FEC + DOCETAXEL |
| 20023065 | 20009784 | 1.65 | 89.8 | Adjuvant (A) | 2015-05-20 | 2015-05-22 | FEC 100 + DOCETAXEL | 02 | Y | 20081404 | FEC + DOCETAXEL |
| 20023066 | 20009784 | 1.57 | 75.4 | Curative (C) | null | 2015-09-14 | FEC + DOCETAXEL | N | N | 20081404 | FEC + DOCETAXEL |
| 20023067 | 20009785 | 1.62 | 77.3 | Curative (C) | 2013-10-02 | 2013-10-06 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20081418 | FEC + DOCETAXEL |
| 20023068 | 20009785 | 1.64 | 101.2 | Adjuvant (A) | null | 2015-07-04 | FEC 100 + DOCETAXEL | N | N | 20081418 | FEC + DOCETAXEL |
| 20023069 | 20009786 | 1.64 | 116 | Adjuvant (A) | 2015-12-09 | 2015-12-12 | FEC + DOCETAXEL | 02 | null | 20081427 | FEC + DOCETAXEL |
| 20023070 | 20009787 | 1.71 | 125 | Adjuvant (A) | 2017-06-20 | 2017-07-11 | FEC + DOCETAXEL | 2 | N | 20081429 | FEC + DOCETAXEL |
| 20023071 | 20009787 | 1.69 | null | Adjuvant (A) | 2015-01-03 | 2015-01-14 | FEC + DOCETAXEL | N | N | 20081429 | FEC + DOCETAXEL |
| 20023072 | 20009788 | 1.67 | 50.8 | Neo-adjuvant (N) | 2017-07-19 | 2017-07-29 | FEC + DOCETAXEL | 2 | N | 20081432 | FEC + DOCETAXEL |
| 20023073 | 20009788 | 1.61 | 63 | Adjuvant (A) | 2015-12-15 | 2015-12-17 | FEC 100 + DOCETAXEL | 2 | N | 20081432 | FEC + DOCETAXEL |
| 20023074 | 20009789 | 1.66 | 60.8 | Adjuvant (A) | 2015-07-05 | 2015-07-05 | FEC + DOCETAXEL | 02 | N | 20081442 | FEC + DOCETAXEL |
| 20023075 | 20009789 | 1.61 | 79.1 | Neo-adjuvant (N) | null | 2016-12-14 | FEC + DOCETAXEL | N | N | 20081442 | FEC + DOCETAXEL |
| 20023076 | 20009790 | 1.72 | 92.1 | null | 2014-05-14 | 2014-05-28 | FEC 100 + DOCETAXEL | N | N | 20081452 | FEC + DOCETAXEL |
| 20023077 | 20009790 | 1.64 | 109 | Curative (C) | 2015-11-09 | 2015-11-17 | FEC 100 + DOCETAXEL | 2 | N | 20081452 | FEC + DOCETAXEL |
| 20023078 | 20009790 | 1.52 | 65 | Adjuvant (A) | 2017-10-04 | 2017-10-07 | FEC + DOCETAXEL | 02 | null | 20081452 | FEC + DOCETAXEL |
| 20023079 | 20009791 | null | 88.5 | Adjuvant (A) | 2014-01-11 | 2014-02-03 | FEC + DOCETAXEL | N | N | 20081463 | FEC + DOCETAXEL |
| 20023080 | 20009791 | 1.56 | null | null | 2015-08-18 | 2015-09-01 | FEC + DOCETAXEL | N | N | 20081463 | FEC + DOCETAXEL |
| 20023081 | 20009791 | 1.56 | 72.7 | Adjuvant (A) | 2014-11-17 | 2014-11-21 | FEC + DOCETAXEL | 2 | N | 20081463 | FEC + DOCETAXEL |
| 20023082 | 20009791 | 1.74 | 69 | Not known (9) | 2017-01-31 | 2017-02-21 | FEC 100 + DOCETAXEL | N | N | 20081463 | FEC + DOCETAXEL |
| 20023083 | 20137750 | 1.62 | 67 | Adjuvant (A) | 2013-07-07 | 2013-07-22 | FEC + DOCETAXEL | 2 | N | 20081485 | FEC + DOCETAXEL |
| 20023084 | 20009792 | 1.67 | 63.6 | Adjuvant (A) | 2016-11-03 | 2016-11-24 | FEC 100 + DOCETAXEL | N | N | 20081488 | FEC + DOCETAXEL |
| 20023085 | 20009793 | 1.74 | 73.5 | Disease modification (D) | 2017-08-03 | 2017-08-04 | FEC 100 + DOCETAXEL | 02 | null | 20081489 | FEC + DOCETAXEL |
| 20023086 | 20009794 | 1.62 | 68.8 | Neo-adjuvant (N) | 2015-08-13 | 2015-08-21 | FEC 100 + DOCETAXEL | 02 | N | 20081491 | FEC + DOCETAXEL |
| 20023087 | 20009795 | null | null | Adjuvant (A) | 2014-06-30 | 2014-07-22 | FEC + DOCETAXEL | N | N | 20081497 | FEC + DOCETAXEL |
| 20023088 | 20009795 | 1.63 | 73.35 | Adjuvant (A) | 2015-05-10 | 2015-05-26 | FEC + DOCETAXEL | 02 | N | 20081497 | FEC + DOCETAXEL |
| 20023089 | 20009796 | 1.64 | 60.2 | Adjuvant (A) | 2013-11-20 | 2013-11-29 | FEC + DOCETAXEL | N | N | 20081503 | FEC + DOCETAXEL |
| 20023090 | 20070613 | 1.54 | 66.1 | Adjuvant (A) | 2013-05-17 | 2013-06-03 | FEC + DOCETAXEL | 02 | N | 20081504 | FEC + DOCETAXEL |
| 20023091 | 20009797 | 1.7 | 48.2 | Not known (9) | 2013-08-08 | 2013-08-08 | FEC + DOCETAXEL | 02 | Y | 20081510 | FEC + DOCETAXEL |
| 20023092 | 20009798 | 1.71 | 74.9 | Adjuvant (A) | 2015-10-17 | 2015-10-26 | FEC + DOCETAXEL | N | N | 20081514 | FEC + DOCETAXEL |
| 20023093 | 20009798 | 1.63 | 59.5 | Not known (9) | 2015-02-14 | 2015-02-24 | FEC 100 + DOCETAXEL | 2 | N | 20081514 | FEC + DOCETAXEL |
| 20023094 | 20009799 | 1.56 | 78.3 | Curative (C) | 2013-09-24 | 2013-10-01 | FEC + DOCETAXEL | 02 | N | 20081516 | FEC + DOCETAXEL |
| 20023095 | 20009799 | 1.63 | 53 | Neo-adjuvant (N) | null | 2014-08-20 | FEC 100 + DOCETAXEL | N | N | 20081516 | FEC + DOCETAXEL |